STAT

10/19/2026

"I wish that medical aid in dying had been an option for her. At the very least, it would have offered her a more comfortable death — and my brothers and me a less complicated grief. And maybe, just maybe, it could have saved her. " https://bit.ly/3U6LMTa

10/19/2026

The Republican party’s confusing messaging on vaccines is going to hurt candidates in the midterms, two former GOP congressmen argue.

The Republican party’s confusing messaging on vaccines is going to hurt candidates in the midterms, two former GOP congressmen argue.

10/19/2026

Roche is reviewing all future investments in Germany over health care cost-cutting ​policies, with a top executive citing a loss of trust

Roche is reviewing all future investments in Germany over health care cost-cutting ​policies, with a top executive citing a loss of trust

10/19/2026

Internal emails obtained by STAT show that the American Association of Immunologists is sharply divided over California's Proposition 38, even though it would provide $8.4 billion in taxpayer dollars for…

Internal emails obtained by STAT show that the American Association of Immunologists is sharply divided over California's Proposition 38, even though it would provide $8.4 billion in taxpayer dollars for the type of research its members do.

10/19/2026

Isomorphic Labs wants to turn its technology into an engine for new medicines. The question now is whether — and how — it can deliver on that promise.

Isomorphic Labs wants to turn its technology into an engine for new medicines. The question now is whether — and how — it can deliver on that promise.

10/19/2026

A STAT investigation found that several nonprofits are raking in massive sums by acting as arbitrators in a program that helps protect patients from surprise medical bills.

A STAT investigation found that several nonprofits are raking in massive sums by acting as arbitrators in a program that helps protect patients from surprise medical bills.

10/19/2026

An oral treatment from Gilead Sciences eliminated the symptoms experienced by patients with a type of inflammatory bowel disease, according to mid-stage study results reported Monday.

An oral treatment from Gilead Sciences eliminated the symptoms experienced by patients with a type of inflammatory bowel disease, according to mid-stage study results reported Monday.

10/19/2026

"The hardest years of my life," is how Cambridge scientist David Sabatini describes the time since his downfall from MIT.

"The hardest years of my life," is how Cambridge scientist David Sabatini describes the time since his downfall from MIT.

10/17/2026

Merck and Moderna have ‘lot of exploring to do’ after initial cancer vaccine success. The companies are now looking to prove the vaccine isn’t just a powerful tool for certain melanoma patients.

Stephen Hoge and Dean Li, at the STAT Summit, spoke of how Merck and Moderna will pair Keytruda with personalized mRNA vaccines to target tumors.

10/17/2026

A jury awarded $6 million in damages to scientist David Sabatini, whose career imploded after he was accused by a much younger colleague of inappropriate sexual conduct in his lab.

A jury awarded $6 million in damages to scientist David Sabatini, whose career imploded after he was accused by a much younger colleague of inappropriate sexual conduct in his lab.